These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1792661)
1. [Diarrhea caused by Cyclo 3 fort]. Mornet M; Boisserie P; Jonville AP; Hamon B; Gauchez AS; Soyez C Therapie; 1991; 46(3):254. PubMed ID: 1792661 [No Abstract] [Full Text] [Related]
2. An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency. Beltramino R; Penenory A; Buceta AM Int Angiol; 1999 Dec; 18(4):337-42. PubMed ID: 10811525 [TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of a single daily dose of two capsules Cyclo 3 Fort in the morning versus a repeated dose of one capsule morning and noon. A one-month study. Boccalon H; Causse C; Yubero L Int Angiol; 1998 Sep; 17(3):155-60. PubMed ID: 9821028 [TBL] [Abstract][Full Text] [Related]
5. An open-label, randomized multicenter study comparing the efficacy and safety of Cyclo 3 Fort versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency. Beltramino R; Penenory A; Buceta AM Angiology; 2000 Jul; 51(7):535-44. PubMed ID: 10917578 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency. Boyle P; Diehm C; Robertson C Int Angiol; 2003 Sep; 22(3):250-62. PubMed ID: 14612852 [TBL] [Abstract][Full Text] [Related]
7. [Diarrhea induced by Cyclo 3 fort and lymphocytic colitis]. Ouyahya F; Codjovi P; Machet MC; Oliver JM; Dorval ED; Metman EH Gastroenterol Clin Biol; 1993; 17(1):65-6. PubMed ID: 8467976 [No Abstract] [Full Text] [Related]
10. [Treatment of angiodystrophic skin diseases with ginkgo-biloba]. Nazzaro P; Di Carlo A Minerva Med; 1973 Nov; 64(79 Suppl):4198-200. PubMed ID: 4592297 [No Abstract] [Full Text] [Related]
11. [Venous insufficiency of the lower limbs. Controlled study of the action of Cyclo 3]. Elbaz C; Nebot F; Reinharez D Phlebologie; 1976; 29(1):77-84. PubMed ID: 792902 [No Abstract] [Full Text] [Related]
12. [Pseudolupus induced by a vasculotropic drug (author's transl)]. Guardia J; Richart C; Martinez Vàzquez JM; Martin C Nouv Presse Med; 1977 Oct; 6(32):2873-5. PubMed ID: 917804 [TBL] [Abstract][Full Text] [Related]
14. Correlation between improvement in functional signs and plethysmographic parameters during venoactive treatment (Cyclo 3 Fort). Allaert FA; Hugue C; Cazaubon M; Renaudin JM; Clavel T; Escourrou P Int Angiol; 2011 Jun; 30(3):272-7. PubMed ID: 21617611 [TBL] [Abstract][Full Text] [Related]
15. Effects of Cyclo 3 Fort on microvascular reactivity and the venoarteriolar reflex in diabetic hamsters. Bouskela E; Cyrino FZ; Bougaret S Clin Hemorheol Microcirc; 1997; 17(5):351-6. PubMed ID: 9502532 [TBL] [Abstract][Full Text] [Related]
16. Treatment of secondary lymphedema of the upper limb with CYCLO 3 FORT. Cluzan RV; Alliot F; Ghabboun S; Pascot M Lymphology; 1996 Mar; 29(1):29-35. PubMed ID: 8721977 [TBL] [Abstract][Full Text] [Related]
17. [Clinico-statistical study on the activity of a phlebo-active drug Fleboplex in obstetrical and gynecologic pathology]. Ricci MG Minerva Ginecol; 1974 Nov; 26(11):641-6. PubMed ID: 4444806 [No Abstract] [Full Text] [Related]
18. [Chronic diarrhea during treatment with Veinotonyl 75]. Raoul JL; Dautreme S; Heresbach N; Bretagne JF; Gosselin M Ann Gastroenterol Hepatol (Paris); 1994; 30(1):25. PubMed ID: 8192420 [No Abstract] [Full Text] [Related]
19. Pharmacological targets of drugs employed in chronic venous and lymphatic insufficiency. Boisseau MR Int Angiol; 2002 Jun; 21(2 Suppl 1):33-9. PubMed ID: 12515978 [TBL] [Abstract][Full Text] [Related]